Dual nucleoside therapy in resource-poor and medium-income countries
Clin Infect Dis
.
1999 Sep;29(3):706-7.
doi: 10.1086/598674.
Authors
R Colebunders
,
K Verdonck
PMID:
10530487
DOI:
10.1086/598674
No abstract available
Publication types
Comment
Letter
MeSH terms
Anti-HIV Agents / economics*
Anti-HIV Agents / therapeutic use*
Developing Countries
Drug Therapy, Combination
HIV Infections / drug therapy*
HIV Infections / economics*
Humans
Medical Indigency*
Poverty
Substances
Anti-HIV Agents